These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2927252)

  • 1. Effect of LY53857, a selective 5HT2 receptor antagonist, on 5HT-induced increases in cutaneous vascular permeability in rats.
    Cohen ML; Schenck K
    Life Sci; 1989; 44(14):957-61. PubMed ID: 2927252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
    Cohen ML; Fuller RW; Kurz KD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine, but not rat bladder contracts to serotonin via activation of 5HT2 receptors.
    Cohen ML
    J Urol; 1990 May; 143(5):1037-40. PubMed ID: 2139474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of serotonin-amplified human platelet aggregation by ketanserin, ritanserin, and the ergoline 5HT2 receptor antagonists-LY53857, sergolexole, and LY237733.
    McBride PA; Mann JJ; Nimchinsky E; Cohen ML
    Life Sci; 1990; 47(23):2089-95. PubMed ID: 2125095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the 5-HT2 receptor in the regulation of sexual performance of male rats.
    Foreman MM; Hall JL; Love RL
    Life Sci; 1989; 45(14):1263-70. PubMed ID: 2811596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serotonin (5HT2) receptor blockade in myocardial reperfusion injury: effects of LY53857 in a canine model of myocardial infarction.
    Simpson PJ; Schelm JA; Jakubowski JA; Smallwood JK
    J Pharmacol Exp Ther; 1991 Sep; 258(3):979-85. PubMed ID: 1653847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
    Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amesergide and structurally related nor-D-ergolines: 5HT2 receptor interactions in the rat.
    Martinelli MJ; Bloomquist W; Peterson BC; Cohen ML
    J Med Chem; 1993 Sep; 36(18):2671-5. PubMed ID: 8410979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin-induced pulmonary responses in the perfused guinea pig lung: evidence for 5HT2 receptor-mediated pulmonary vascular and airway smooth muscle constriction.
    Selig WM; Bloomquist MA; Cohen ML; Fleisch JH
    Pulm Pharmacol; 1988; 1(2):93-9. PubMed ID: 2980293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serotonin 5-HT2 receptor system, but not the alpha 1-adrenergic receptor system, is involved in the estrogen-induced afternoon prolactin surge in the rat.
    Pan JT; Gala RR
    Life Sci; 1988; 42(19):1869-74. PubMed ID: 2835566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5HT2 receptors in the rat portal vein: desensitization following cumulative serotonin addition.
    Lemberger HF; Mason N; Cohen ML
    Life Sci; 1984 Jul; 35(1):71-7. PubMed ID: 6738305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (8 beta)-Ergoline-8-carboxylic acid cycloalkyl esters as serotonin antagonists: structure-activity study.
    Garbrecht WL; Marzoni G; Whitten KR; Cohen ML
    J Med Chem; 1988 Feb; 31(2):444-8. PubMed ID: 3339614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of laboratory anaesthetics on the increased cutaneous vascular permeability responses to histamine and 5-hydroxytryptamine in rats.
    O'Duffy G; Chahl LA
    J Pharmacol Methods; 1980 Nov; 4(3):231-5. PubMed ID: 7442268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of season and anaesthetic on cutaneous vascular permeability responses to histamine, serotonin and mast cell-releasing agents in rats.
    Chahl LA
    Clin Exp Pharmacol Physiol; 1983; 10(4):415-20. PubMed ID: 6194925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LY53857, a 5HT2 receptor antagonist, delays occlusion and inhibits platelet aggregation in a rabbit model of carotid artery occlusion.
    Wilson HC; Coffman W; Killam AL; Cohen ML
    Thromb Haemost; 1991 Sep; 66(3):355-60. PubMed ID: 1746008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of serotonin receptor antagonists on PAG stimulation induced aversion: different contributions of 5HT1, 5HT2 and 5HT3 receptors.
    Jenck F; Broekkamp CL; Van Delft AM
    Psychopharmacology (Berl); 1989; 97(4):489-95. PubMed ID: 2498946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin-induced pulmonary responses are mediated by the 5-HT2 receptor in the mouse.
    Martin TR; Cohen ML; Drazen JM
    J Pharmacol Exp Ther; 1994 Jan; 268(1):104-9. PubMed ID: 8301545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specificity of ketanserin in the inhibition of serotonin-induced steroidogenesis in the rat adrenal zona glomerulosa.
    Williams BC; Shaikh S; Edwards CR
    J Hypertens Suppl; 1984 Dec; 2(3):S559-61. PubMed ID: 6100754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.